Is Japanese cellular immunotherapy effective in preventing recurrence and metastasis of lung cancer?

Japanese cellular immunotherapy is an effective method, which can eliminate the latent and residual cancer cells after operation, prevent the recurrence and metastasis of lung cancer, enhance the tolerance of radiotherapy and chemotherapy, reduce the side effects of radiotherapy and chemotherapy, improve the quality of life of patients and achieve a very good prognosis. Cellular immunotherapy in Japan is different from short-term drug therapy. Immune cells can exist in the body for a long time and belong to the immune memory function of the body. The activated anti-cancer ability and massive proliferation of immune cells can last for a period of time in the body and play a role in killing tumors continuously, which is the biggest feature that distinguishes Japanese cellular immunotherapy from other drug treatments. Hong Kong and Anhang Health believe that when choosing a method to prevent recurrence and metastasis of lung cancer, we should not only consider the killing ability of tumor cells, but also consider the interference degree and toxic side effects of this treatment method on the internal environment of the body.